Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 2/20 | 0.49 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | CCR3 | P51677 | 1/20 | 0.42 |
| ▸ | NPFFR1 | Q9GZQ6 | 1/20 | 0.42 |
| ▸ | NPFFR2 | Q9Y5X5 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5792327 | 0.86 | ALDH1A1 (0.42) | ALDH1A1ATMCCR3NPFFR1NPFFR2 | |
| Hydrochloric Acid SCHEMBL5758292 | 0.84 | ALDH1A1 (0.46) | CARM1PRMT6ALDH1A1ATMCCR3 | |
| Benzylamine SCHEMBL5824111 | 0.83 | ALDH1A1 (0.43) | CARM1PRMT6ALDH1A1ATMCCR3 | |
| SCHEMBL6206654 | 0.81 | CARM1 (0.50) | CARM1PRMT6SIGMAR1 | |
| SCHEMBL6007980 | 0.78 | CARM1 (0.52) | CARM1PRMT6ALDH1A1ATMCCR3 | |
| SCHEMBL6009428 | 0.74 | ALDH1A1 (0.53) | CARM1PRMT6ALDH1A1ATMCCR3 | |
| Hydrochloric Acid SCHEMBL6007421 | 0.73 | ALDH1A1 (0.52) | CARM1PRMT6ALDH1A1ATMCCR3 | |
| SCHEMBL27014972 | 0.73 | HRH3 (0.50) | CCR3HRH3SIGMAR1 | |
| SCHEMBL6007453 | 0.72 | ALDH1A1 (0.49) | CARM1PRMT6ALDH1A1ATMCCR3 | |
| Hydrochloric Acid SCHEMBL8905427 | 0.72 | CARM1 (0.53) | CARM1PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7078537-B2 | Phenylalkyl diamine and amide analogs | SK CORPORATION (KR) | 2006-07-18 | — | — | US | disclosed |
| US-20030105079-A1 | Novel phenylalkyl diamine and amide analogs | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105079-A1 | Novel phenylalkyl diamine and amide analogs | SIGMAR1, TAAR1, OPRL1 | CARM1 4111/4885PRMT6 1600/4885ALDH1A1 639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.